Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129027) titled 'Clinical Study on the Diagnosis and Treatment of Patients with Advanced Solid Tumors Using ¹77Lu-FAPI' on July 29.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The Affiliated Hospital of Inner Mongolia Medical University

Condition: Advanced malignant solid tumours confirmed by histological or cytological examination

Intervention: Experimental Group:Treatment with 177Lu-FAPI injection is administered using a dose-escalation protocol

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-07-30

Target Sample Size: Experimental Group:12;

Countries ...